Interactive + Gaming

Stephen Goodman, Co-Chair of Pryor Cashman’s Life Sciences Group and co-founder of Mid Atlantic Bio Angels (MABA), was quoted in the press regarding a historic tie victory at the 2016 MABA 1^st Pitch Life Science New Jersey competition.

The joint “Best in Show” winners were Lynkogen, Inc., a pre-clinical stage biotech company developing transformative protein therapeutics for devastating metabolic diseases, and Dina Pharmaceuticals, Inc., an emerging pre-clinical stage pharma company developing a novel and unique approach to treating Parkinson’s Disease.

“Both Lynkogen and Dina made dynamic presentations for innovative scientific ideas and demonstrated a willingness to listen carefully to questions and comments. The combination bodes well for the future of each company,” Goodman said.

The full press announcement can be found at Yahoo! Finance and EconoTimes, among other outlets.

More About 1^st Pitch Life Science

Each year, MABA invites early stage life sciences and healthcare companies to present before a panel of experienced life science investors and consultants, followed by a short audience Q&A. Presenters at 1^st Pitch then have the unique benefit of hearing first-hand from the panel as they offer a constructive critique of their business model and perceived viability in the market.

Pryor Cashman’s Life Sciences Practice

Our Life Sciences attorneys actively nurture entrepreneurs from the onset of their new ventures, advising on how best to structure their businesses and implement choices, acquiring rights to core technologies and connecting them with potential funding sources such as angel investors, institutional investors, and biotech and health care company venture arms.

We shepherd our clients through transactions, ensuring their critical innovations are protected, and help them secure the best minds and scientific talent to bring their technologies to the global market.

To learn more about our experience in this area, please visit our practice page.